330 related articles for article (PubMed ID: 27083555)
1. The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.
Verrecchia E; Zampetti A; Antuzzi D; Ricci R; Ferri L; Morrone A; Feliciani C; Dagna L; Manna R
Eur J Intern Med; 2016 Jul; 32():26-30. PubMed ID: 27083555
[TBL] [Abstract][Full Text] [Related]
2. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
3. Beneficial screening of Fabry disease in patients with hypohidrosis.
Nagai-Sangawa M; Fukunaga A; Takeuchi C; Nishiyama S; Horikawa T; Nagano C; Nozu K; Fujii H; Nishigori C
J Dermatol; 2022 Feb; 49(2):308-312. PubMed ID: 34796992
[TBL] [Abstract][Full Text] [Related]
4. Late-onset Fabry disease associated with angiokeratoma of Fordyce and multiple cherry angiomas.
Hogarth V; Dhoat S; Mehta AB; Orteu CH
Clin Exp Dermatol; 2011 Jul; 36(5):506-8. PubMed ID: 21457158
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
6. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
Rosa Neto NS; Bento JCB; Pereira RMR
Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous complications of Anderson-Fabry disease.
Giuseppe P; Daniele R; Rita BM
Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
[TBL] [Abstract][Full Text] [Related]
8. Recurrent fever of unknown origin: An overlooked symptom of Fabry disease.
Luo Y; Wu D; Shen M
Mol Genet Genomic Med; 2020 Oct; 8(10):e1454. PubMed ID: 32797665
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease 'The New Great Imposter': results of the French Observatoire in Internal Medicine Departments (FIMeD).
Lidove O; Kaminsky P; Hachulla E; Leguy-Seguin V; Lavigne C; Marie I; Maillot F; Serratrice C; Masseau A; Chérin P; Cabane J; Noel E;
Clin Genet; 2012 Jun; 81(6):571-7. PubMed ID: 21623772
[TBL] [Abstract][Full Text] [Related]
10. Neurological complications of Anderson-Fabry disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
[TBL] [Abstract][Full Text] [Related]
11. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.
Terryn W; Cochat P; Froissart R; Ortiz A; Pirson Y; Poppe B; Serra A; Van Biesen W; Vanholder R; Wanner C
Nephrol Dial Transplant; 2013 Mar; 28(3):505-17. PubMed ID: 23234755
[TBL] [Abstract][Full Text] [Related]
12. Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy.
Gaggl M; Lajic N; Heinze G; Voigtländer T; Sunder-Plassmann R; Paschke E; Fauler G; Sunder-Plassmann G; Mundigler G
Int J Med Sci; 2016; 13(5):340-6. PubMed ID: 27226774
[TBL] [Abstract][Full Text] [Related]
13. Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.
Zampetti A; Orteu CH; Antuzzi D; Bongiorno MR; Manco S; Gnarra M; Morrone A; Cardinali G; Kovacs D; Aspite N; Linder D; Parini R; Feliciani C;
Br J Dermatol; 2012 Apr; 166(4):712-20. PubMed ID: 22452439
[TBL] [Abstract][Full Text] [Related]
14. Fabry disease.
Tarabuso AL
Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
[TBL] [Abstract][Full Text] [Related]
16. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance.
Smid BE; van der Tol L; Cecchi F; Elliott PM; Hughes DA; Linthorst GE; Timmermans J; Weidemann F; West ML; Biegstraaten M; Lekanne Deprez RH; Florquin S; Postema PG; Tomberli B; van der Wal AC; van den Bergh Weerman MA; Hollak CE
Int J Cardiol; 2014 Dec; 177(2):400-8. PubMed ID: 25442977
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum of Anderson Fabry disease in a Romanian family.
Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
[TBL] [Abstract][Full Text] [Related]
18. Fabry disease: treatment and diagnosis.
Rozenfeld PA
IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
[TBL] [Abstract][Full Text] [Related]
19. Exocrine pancreatic insufficiency is not a cause of abdominal complaints in patients with Fabry disease.
Vujasinovic M; Tepes B; Vujkovac B; Cokan Vujkovac A; Tretjak M; Korat V
Wien Klin Wochenschr; 2015 Dec; 127(23-24):931-4. PubMed ID: 25835592
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease: recognition and management of cutaneous manifestations.
Möhrenschlager M; Braun-Falco M; Ring J; Abeck D
Am J Clin Dermatol; 2003; 4(3):189-96. PubMed ID: 12627994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
